Created in July 2017, Biocensy (Cesson-Sévigné) raised 800,000 euros in March from several regional investors to develop its medical monitoring and prevention device dedicated to respiratory insufficiency. It is more specifically a question of a non-invasive sensor connected to a remote monitoring platform for ambulatory monitoring of patients with chronic obstructive pulmonary disease (COPD).

With this fundraising, the start-up plans to finance the industrialisation of its medical device, to obtain the CE mark by the end of 2018, to carry out a clinical study of remote monitoring of patients treated for COPD, and to construct a crisis prevention solution for the same patients.

Biosency aims to become a major player in this market, first in France but also rapidly in Northern Europe. The industrialisation of the device is planned with a company from Saint-Malo.


Sources : Lettre API – 25/09/2017, Ouest France – 29/03/2018